<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35925863</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2423</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Glycobiology</Title><ISOAbbreviation>Glycobiology</ISOAbbreviation></Journal><ArticleTitle>Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19.</ArticleTitle><Pagination><StartPage>871</StartPage><EndPage>885</EndPage><MedlinePgn>871-885</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/glycob/cwac051</ELocationID><Abstract><AbstractText>Disease development and progression are often associated with aberrant glycosylation, indicating that changes in biological fluid glycome may potentially serve as disease signatures. The corona virus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a significant threat to global human health. However, the effect of SARS-CoV-2 infection on the overall serum N-glycomic profile has been largely unexplored. Here, we extended our 96-well-plate-based high-throughput, high-sensitivity N-glycan profiling platform further with the aim of elucidating potential COVID-19-associated serum N-glycomic alterations. Use of this platform revealed both similarities and differences between the serum N-glycomic fingerprints of COVID-19 positive and control cohorts. Although there were no specific glycan peaks exclusively present or absent in COVID-19 positive cohort, this cohort showed significantly higher levels of glycans and variability. On the contrary, the overall N-glycomic profiles for healthy controls were well-contained within a narrow range. From the serum glycomic analysis, we were able to deduce changes in different glycan subclasses sharing certain structural features. Of significance was the hyperbranched and hypersialylated glycans and their derived glycan subclass traits. T-distributed stochastic neighbor embedding and hierarchical heatmap clustering analysis were performed to identify 13 serum glycomic variables that potentially distinguished the COVID-19 positive from healthy controls. Such serum N-glycomic changes described herein may indicate or correlate to the changes in serum glycoproteins upon COVID-19 infection. Furthermore, mapping the serum N-glycome following SARS-CoV-2 infection may help us better understand the disease and enable "Long-COVID" surveillance to capture the full spectrum of persistent symptoms.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yongjing</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5482-5743</Identifier><AffiliationInfo><Affiliation>National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co., Dublin, A94 X099, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4907-3652</Identifier><AffiliationInfo><Affiliation>National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co., Dublin, A94 X099, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Glycobiology</MedlineTA><NlmUniqueID>9104124</NlmUniqueID><ISSNLinking>0959-6658</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011134">Polysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054794" MajorTopicYN="Y">Glycomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011134" MajorTopicYN="N">Polysaccharides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">InstantPC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">protein glycosylation</Keyword><Keyword MajorTopicYN="N">serum glycomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35925863</ArticleId><ArticleId IdType="pmc">PMC9487901</ArticleId><ArticleId IdType="doi">10.1093/glycob/cwac051</ArticleId><ArticleId IdType="pii">6655861</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adamczyk &#xa0;B, Struwe &#xa0;WB, Ercan &#xa0;A, Nigrovic &#xa0;PA, Rudd &#xa0;PM. Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis. J Proteome Res. 2013:12:444&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">23151259</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler &#xa0;B, Faine &#xa0;S, Gordon &#xa0;LM. The enzyme-linked immunosorbent assay (ELISA) as a serological test for detecting antibodies against Leptospira interrogans serovar hardjo in sheep. Aust Vet J. 1981:57:414&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">7034708</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad &#xa0;H, Taghrir &#xa0;MH, Abdollahi &#xa0;A, Ghahramani &#xa0;N, Kumar &#xa0;M, Paydar &#xa0;S, Razani &#xa0;B, Mwangi &#xa0;J, Asadi-Pooya &#xa0;AA, Malekmakan &#xa0;L, et al. &#xa0;Long COVID, a comprehensive systematic scoping review. Infection. 2021:49:1163&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinkuolie &#xa0;AO, Buring &#xa0;JE, Ridker &#xa0;PM, Mora &#xa0;S. A novel protein glycan biomarker and future cardiovascular disease events. J Am Heart Assoc. 2014:3:e001221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4323825</ArticleId><ArticleId IdType="pubmed">25249300</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly &#xa0;Z, Xie &#xa0;Y, Bowe &#xa0;B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021:594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan &#xa0;NA. The road to addressing long Covid. Science. 2021:373:491&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan &#xa0;NA, Johnson &#xa0;L. Defining long COVID: going back to the start. Med (N Y). 2021:2:501&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7992371</ArticleId><ArticleId IdType="pubmed">33786465</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat &#xa0;F, Stadlbauer &#xa0;D, Strohmeier &#xa0;S, Nguyen &#xa0;THO, Chromikova &#xa0;V, McMahon &#xa0;M, Jiang &#xa0;K, Arunkumar &#xa0;GA, Jurczyszak &#xa0;D, Polanco &#xa0;J, et al. &#xa0;A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020:26:1033&#x2013;1036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183627</ArticleId><ArticleId IdType="pubmed">32398876</ArticleId></ArticleIdList></Reference><Reference><Citation>An &#xa0;HJ, Kronewitter &#xa0;SR, de &#xa0;Leoz &#xa0;ML, Lebrilla &#xa0;CB. Glycomics and disease markers. Curr Opin Chem Biol. 2009:13:601&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2788081</ArticleId><ArticleId IdType="pubmed">19775929</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold &#xa0;JN, Wormald &#xa0;MR, Suter &#xa0;DM, Radcliffe &#xa0;CM, Harvey &#xa0;DJ, Dwek &#xa0;RA, Rudd &#xa0;PM, Sim &#xa0;RB. Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem. 2005:280:29080&#x2013;29087.</Citation><ArticleIdList><ArticleId IdType="pubmed">15955802</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam &#xa0;B, Basit &#xa0;M, Nisar &#xa0;MA, Khurshid &#xa0;M, Rasool &#xa0;MH. Proteomics: technologies and their applications. J Chromatogr Sci. 2017:55:182&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">28087761</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagdonaite &#xa0;I, Wandall &#xa0;HH. Global aspects of viral glycosylation. Glycobiology. 2018:28:443&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108637</ArticleId><ArticleId IdType="pubmed">29579213</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley &#xa0;R, Kearns &#xa0;N, Hills &#xa0;T. Charting a course for the management of long COVID. Lancet Respir Med. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8372495</ArticleId><ArticleId IdType="pubmed">34416190</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnke &#xa0;J, Cohen &#xa0;AM, LaRoche &#xa0;J. N-linked glycosylation enzymes in the diatom Thalassiosira oceanica exhibit a diel cycle in transcript abundance and favor for NXT-type sites. Sci Rep. 2021:11:3227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864949</ArticleId><ArticleId IdType="pubmed">33547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Boopathi &#xa0;S, Poma &#xa0;AB, Kolandaivel &#xa0;P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2021:39:3409&#x2013;3418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196923</ArticleId><ArticleId IdType="pubmed">32306836</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess &#xa0;S, Collaboration CCG . Identifying the odds ratio estimated by a two-stage instrumental variable analysis with a logistic regression model. Stat Med. 2013:32:4726&#x2013;4747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935453</ArticleId><ArticleId IdType="pubmed">23733419</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter &#xa0;LJ, Garner &#xa0;LV, Smoot &#xa0;JW, Li &#xa0;Y, Zhou &#xa0;Q, Saveson &#xa0;CJ, Sasso &#xa0;JM, Gregg &#xa0;AC, Soares &#xa0;DJ, Beskid &#xa0;TR, et al. &#xa0;Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 2020:6:591&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197457</ArticleId><ArticleId IdType="pubmed">32382657</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalino &#xa0;L, Gaieb &#xa0;Z, Goldsmith &#xa0;JA, Hjorth &#xa0;CK, Dommer &#xa0;AC, Harbison &#xa0;AM, Fogarty &#xa0;CA, Barros &#xa0;EP, Taylor &#xa0;BC, McLellan &#xa0;JS, et al. &#xa0;Beyond shielding: the roles of glycans in the SARS-CoV-2 spike protein. ACS Cent Sci. 2020:6:1722&#x2013;1734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523240</ArticleId><ArticleId IdType="pubmed">33140034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng &#xa0;MP, Papenburg &#xa0;J, Desjardins &#xa0;M, Kanjilal &#xa0;S, Quach &#xa0;C, Libman &#xa0;M, Dittrich &#xa0;S, Yansouni &#xa0;CP. Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a narrative review. Ann Intern Med. 2020:172:726&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170415</ArticleId><ArticleId IdType="pubmed">32282894</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerc &#xa0;F, Reiding &#xa0;KR, Jansen &#xa0;BC, Kammeijer &#xa0;GS, Bondt &#xa0;A, Wuhrer &#xa0;M. Human plasma protein N-glycosylation. Glycoconj J. 2016:33:309&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4891372</ArticleId><ArticleId IdType="pubmed">26555091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan &#xa0;JM, Mateus &#xa0;J, Kato &#xa0;Y, Hastie &#xa0;KM, Yu &#xa0;ED, Faliti &#xa0;CE, Grifoni &#xa0;A, Ramirez &#xa0;SI, Haupt &#xa0;S, Frazier &#xa0;A, et al. &#xa0;Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021:371:eabf4063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong &#xa0;E, Du &#xa0;H, Gardner &#xa0;L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020:20:533&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov &#xa0;I, Hallqvist &#xa0;J, Gilmour &#xa0;KC, Grandjean &#xa0;L, Mills &#xa0;K, Heywood &#xa0;WE. The long tail of Covid-19&#x2032;&#x2014;the detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020:9:1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Everest-Dass &#xa0;AV, Moh &#xa0;ESX, Ashwood &#xa0;C, Shathili &#xa0;AMM, Packer &#xa0;NH. Human disease glycomics: technology advances enabling protein glycosylation analysis&#x2014;part 1. Expert Rev Proteomics. 2018:15:165&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">29285957</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeze &#xa0;HH. Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem. 2013:288:6936&#x2013;6945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591604</ArticleId><ArticleId IdType="pubmed">23329837</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung &#xa0;TS, Liu &#xa0;DX. Post-translational modifications of coronavirus proteins: roles and function. Future Virol. 2018:13:405&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080180</ArticleId><ArticleId IdType="pubmed">32201497</ArticleId></ArticleIdList></Reference><Reference><Citation>Giri &#xa0;B, Pandey &#xa0;S, Shrestha &#xa0;R, Pokharel &#xa0;K, Ligler &#xa0;FS, Neupane &#xa0;BB. Review of analytical performance of COVID-19 detection methods. Anal Bioanal Chem. 2021:413:35&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498299</ArticleId><ArticleId IdType="pubmed">32944809</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong &#xa0;F, Wei &#xa0;HX, Li &#xa0;Q, Liu &#xa0;L, Li &#xa0;B. Evaluation and comparison of serological methods for COVID-19 diagnosis. Front Mol Biosci. 2021:8:682405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343015</ArticleId><ArticleId IdType="pubmed">34368226</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant &#xa0;OC, Montgomery &#xa0;D, Ito &#xa0;K, Woods &#xa0;RJ. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition. Sci Rep. 2020:10:14991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490396</ArticleId><ArticleId IdType="pubmed">32929138</ArticleId></ArticleIdList></Reference><Reference><Citation>Haakensen &#xa0;VD, Steinfeld &#xa0;I, Saldova &#xa0;R, Shehni &#xa0;AA, Kifer &#xa0;I, Naume &#xa0;B, Rudd &#xa0;PM, Borresen-Dale &#xa0;AL, Yakhini &#xa0;Z. Serum N-glycan analysis in breast cancer patients&#x2014;relation to tumour biology and clinical outcome. Mol Oncol. 2016:10:59&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5528923</ArticleId><ArticleId IdType="pubmed">26321095</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajian-Tilaki &#xa0;K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013:4:627&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3755824</ArticleId><ArticleId IdType="pubmed">24009950</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison &#xa0;AG, Lin &#xa0;T, Wang &#xa0;P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020:41:1100&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556779</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart &#xa0;GW, Copeland &#xa0;RJ. Glycomics hits the big time. Cell. 2010:143:672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3008369</ArticleId><ArticleId IdType="pubmed">21111227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmer &#xa0;DW, Lemeshow &#xa0;S. Applied logistic regression. 2nd ed. New York; Chichester: Wiley; 2000</Citation></Reference><Reference><Citation>Huang &#xa0;C, Wang &#xa0;Y, Li &#xa0;X, Ren &#xa0;L, Zhao &#xa0;J, Hu &#xa0;Y, Zhang &#xa0;L, Fan &#xa0;G, Xu &#xa0;J, Gu &#xa0;X, et al. &#xa0;Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020:395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer &#xa0;AS, Jones &#xa0;FK, Nodoushani &#xa0;A, Kelly &#xa0;M, Becker &#xa0;M, Slater &#xa0;D, Mills &#xa0;R, Teng &#xa0;E, Kamruzzaman &#xa0;M, Garcia-Beltran &#xa0;WF, et al. &#xa0;Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020:5:eabe0367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857394</ArticleId><ArticleId IdType="pubmed">33033172</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacofsky &#xa0;D, Jacofsky &#xa0;EM, Jacofsky &#xa0;M. Understanding antibody testing for COVID-19. J Arthroplast. 2020:35:S74&#x2013;S81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184973</ArticleId><ArticleId IdType="pubmed">32389405</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong &#xa0;YT, Choi &#xa0;O, Lim &#xa0;HR, Son &#xa0;YD, Kim &#xa0;HJ, Kim &#xa0;JH. Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression. J Microbiol Biotechnol. 2008:18:1945&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pubmed">19131698</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutzeler &#xa0;CR, Bourguignon &#xa0;L, Weis &#xa0;CV, Tong &#xa0;B, Wong &#xa0;C, Rieck &#xa0;B, Pargger &#xa0;H, Tschudin-Sutter &#xa0;S, Egli &#xa0;A, Borgwardt &#xa0;K, et al. &#xa0;Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020:37:101825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402237</ArticleId><ArticleId IdType="pubmed">32763496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke &#xa0;Z, Oton &#xa0;J, Qu &#xa0;K, Cortese &#xa0;M, Zila &#xa0;V, McKeane &#xa0;L, Nakane &#xa0;T, Zivanov &#xa0;J, Neufeldt &#xa0;CJ, Cerikan &#xa0;B, et al. &#xa0;Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020:588:498&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116492</ArticleId><ArticleId IdType="pubmed">32805734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelm &#xa0;S, Schauer &#xa0;R. Sialic acids in molecular and cellular interactions. Int Rev Cytol. 1997:175:137&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133163</ArticleId><ArticleId IdType="pubmed">9203358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukar &#xa0;M, Guncar &#xa0;G, Vovko &#xa0;T, Podnar &#xa0;S, Cernelc &#xa0;P, Brvar &#xa0;M, Zalaznik &#xa0;M, Notar &#xa0;M, Moskon &#xa0;S, Notar &#xa0;M. COVID-19 diagnosis by routine blood tests using machine learning. Sci Rep. 2021:11:10738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8144373</ArticleId><ArticleId IdType="pubmed">34031483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan &#xa0;J, Ge &#xa0;J, Yu &#xa0;J, Shan &#xa0;S, Zhou &#xa0;H, Fan &#xa0;S, Zhang &#xa0;Q, Shi &#xa0;X, Wang &#xa0;Q, Zhang &#xa0;L, et al. &#xa0;Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020:581:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrilla &#xa0;CB, An &#xa0;HJ. The prospects of glycan biomarkers for the diagnosis of diseases. Mol BioSyst. 2009:5:17&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19081926</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko &#xa0;M, Marzi &#xa0;A, Munster &#xa0;V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020:5:562&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;J. Functional glycomics: methods and protocols. 1st ed. Totowa: Humana Press; 2010.</Citation></Reference><Reference><Citation>Li &#xa0;L, Chen &#xa0;C. Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19). Epidemiol Infect. 2020:148:e164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399149</ArticleId><ArticleId IdType="pubmed">32713370</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;Z, Yi &#xa0;Y, Luo &#xa0;X, Xiong &#xa0;N, Liu &#xa0;Y, Li &#xa0;S, Sun &#xa0;R, Wang &#xa0;Y, Hu &#xa0;B, Chen &#xa0;W, et al. &#xa0;Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020:92:1518&#x2013;1524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228300</ArticleId><ArticleId IdType="pubmed">32104917</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;Y, Liu &#xa0;D, Wang &#xa0;Y, Su &#xa0;W, Liu &#xa0;G, Dong &#xa0;W. The importance of glycans of viral and host proteins in enveloped virus infection. Front Immunol. 2021:12:638573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116741</ArticleId><ArticleId IdType="pubmed">33995356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge &#xa0;S, Nitschke &#xa0;P, Kimhofer &#xa0;T, Wist &#xa0;J, Bong &#xa0;SH, Loo &#xa0;RL, Masuda &#xa0;R, Begum &#xa0;S, Richards &#xa0;T, Lindon &#xa0;JC, et al. &#xa0;Diffusion and relaxation edited proton NMR spectroscopy of plasma reveals a high-fidelity supramolecular biomarker signature of SARS-CoV-2 infection. Anal Chem. 2021:93:3976&#x2013;3986.</Citation><ArticleIdList><ArticleId IdType="pubmed">33577736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe &#xa0;GD, Rumley &#xa0;A, Mackie &#xa0;IJ. Plasma fibrinogen. Ann Clin Biochem. 2004:41:430&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">15588432</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo &#xa0;J, Brakel &#xa0;A, Krizsan &#xa0;A, Ludwig &#xa0;T, Motzing &#xa0;M, Volke &#xa0;D, Lakowa &#xa0;N, Grunewald &#xa0;T, Lehmann &#xa0;C, Wolf &#xa0;J, et al. &#xa0;Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections. Virol J. 2022:19:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934124</ArticleId><ArticleId IdType="pubmed">35305688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma &#xa0;H, Zeng &#xa0;W, He &#xa0;H, Zhao &#xa0;D, Jiang &#xa0;D, Zhou &#xa0;P, Cheng &#xa0;L, Li &#xa0;Y, Ma &#xa0;X, Jin &#xa0;T. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020:17:773&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331804</ArticleId><ArticleId IdType="pubmed">32467617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal &#xa0;S, Barnett &#xa0;J, Brill &#xa0;SE, Brown &#xa0;JS, Denneny &#xa0;EK, Hare &#xa0;SS, Heightman &#xa0;M, Hillman &#xa0;TE, Jacob &#xa0;J, Jarvis &#xa0;HC, et al. &#xa0;'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021:76:396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrekar &#xa0;JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010:5:1315&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pubmed">20736804</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund &#xa0;E, Leach &#xa0;S, Axelsson &#xa0;H, Nystrom &#xa0;K, Norder &#xa0;H, Bemark &#xa0;M, Angeletti &#xa0;D, Lundgren &#xa0;A, Nilsson &#xa0;S, Andersson &#xa0;LM, et al. &#xa0;Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders. PLoS One. 2020:15:e0241104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577439</ArticleId><ArticleId IdType="pubmed">33085715</ArticleId></ArticleIdList></Reference><Reference><Citation>Matrosovich &#xa0;M, Herrler &#xa0;G, Klenk &#xa0;HD. Sialic acid receptors of viruses. Top Curr Chem. 2015:367:1&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7120183</ArticleId><ArticleId IdType="pubmed">23873408</ArticleId></ArticleIdList></Reference><Reference><Citation>Merleev &#xa0;AA, Park &#xa0;D, Xie &#xa0;Y, Kailemia &#xa0;MJ, Xu &#xa0;G, Ruhaak &#xa0;LR, Kim &#xa0;K, Hong &#xa0;Q, Li &#xa0;Q, Patel &#xa0;F, et al. &#xa0;A site-specific map of the human plasma glycome and its age and gender-associated alterations. Sci Rep. 2020:10:17505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567094</ArticleId><ArticleId IdType="pubmed">33060657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nick &#xa0;TG, Campbell &#xa0;KM. Logistic regression. Methods Mol Biol. 2007:404:273&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">18450055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtsubo &#xa0;K, Marth &#xa0;JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006:126:855&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">16959566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ollis &#xa0;AA, Chai &#xa0;Y, DeLisa &#xa0;MP. GlycoSNAP: a high-throughput screening methodology for engineering designer glycosylation enzymes. Methods Mol Biol. 2015:1321:37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">26082213</ArticleId></ArticleIdList></Reference><Reference><Citation>Otvos &#xa0;JD, Shalaurova &#xa0;I, Wolak-Dinsmore &#xa0;J, Connelly &#xa0;MA, Mackey &#xa0;RH, Stein &#xa0;JH, Tracy &#xa0;RP. GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem. 2015:61:714&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pubmed">25779987</ArticleId></ArticleIdList></Reference><Reference><Citation>Padoan &#xa0;A, Sciacovelli &#xa0;L, Basso &#xa0;D, Negrini &#xa0;D, Zuin &#xa0;S, Cosma &#xa0;C, Faggian &#xa0;D, Matricardi &#xa0;P, Plebani &#xa0;M. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: a longitudinal study. Clin Chim Acta. 2020:507:164&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194886</ArticleId><ArticleId IdType="pubmed">32343948</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavic &#xa0;T, Dilber &#xa0;D, Kifer &#xa0;D, Selak &#xa0;N, Keser &#xa0;T, Ljubicic &#xa0;D, Vukic Dugac &#xa0;A, Lauc &#xa0;G, Rumora &#xa0;L, Gornik &#xa0;O. N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease. J Transl Med. 2018:16:323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6249776</ArticleId><ArticleId IdType="pubmed">30463578</ArticleId></ArticleIdList></Reference><Reference><Citation>Qaisieh &#xa0;R, Al-Tamimi &#xa0;M, El-Hammuri &#xa0;N, Shalabi &#xa0;M, Kilani &#xa0;MM, Taha &#xa0;H, Al-Muhtaseb &#xa0;A, Alfarrajin &#xa0;I, Abu Shaqra &#xa0;M, Hamdan &#xa0;A. Clinical, laboratory, and imaging features of COVID-19&#xa0;in a cohort of patients: cross-sectional comparative study. JMIR Public Health Surveill. 2021.&#xa0;7:e28005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457339</ArticleId><ArticleId IdType="pubmed">34081600</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi &#xa0;K, Zeng &#xa0;W, Ye &#xa0;M, Zheng &#xa0;L, Song &#xa0;C, Hu &#xa0;S, Duan &#xa0;C, Wei &#xa0;Y, Peng &#xa0;J, Zhang &#xa0;W, et al. &#xa0;Clinical, laboratory, and imaging features of pediatric COVID-19: a systematic review and meta-analysis. Medicine (Baltimore). 2021:100:e25230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8052054</ArticleId><ArticleId IdType="pubmed">33847620</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu &#xa0;J, Wu &#xa0;C, Li &#xa0;X, Zhang &#xa0;G, Jiang &#xa0;Z, Li &#xa0;X, Zhu &#xa0;Q, Liu &#xa0;L. Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020:71:2255&#x2013;2258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197626</ArticleId><ArticleId IdType="pubmed">32337590</ArticleId></ArticleIdList></Reference><Reference><Citation>Reily &#xa0;C, Stewart &#xa0;TJ, Renfrow &#xa0;MB, Novak &#xa0;J. Glycosylation in health and disease. Nat Rev Nephrol. 2019:15:346&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590709</ArticleId><ArticleId IdType="pubmed">30858582</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo &#xa0;ML. &#xa0;Statistical computing with R. 2nd ed. BocaRaton: Chapman and Hall/ CRC Press, 2019.</Citation></Reference><Reference><Citation>Rodriguez-Morales &#xa0;AJ, Cardona-Ospina &#xa0;JA, Gutierrez-Ocampo &#xa0;E, Villamizar-Pena &#xa0;R, Holguin-Rivera &#xa0;Y, Escalera-Antezana &#xa0;JP, Alvarado-Arnez &#xa0;LE, Bonilla-Aldana &#xa0;DK, Franco-Paredes &#xa0;C, Henao-Martinez &#xa0;AF, et al. &#xa0;Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020:34:101623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102608</ArticleId><ArticleId IdType="pubmed">32179124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross &#xa0;SM. Introductory statistics. 3rd ed. Burlington, MA: Academic Press/Elsevier; 2010</Citation></Reference><Reference><Citation>Saldova &#xa0;R, Asadi Shehni &#xa0;A, Haakensen &#xa0;VD, Steinfeld &#xa0;I, Hilliard &#xa0;M, Kifer &#xa0;I, Helland &#xa0;A, Yakhini &#xa0;Z, Borresen-Dale &#xa0;AL, Rudd &#xa0;PM. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC. J Proteome Res. 2014:13:2314&#x2013;2327.</Citation><ArticleIdList><ArticleId IdType="pubmed">24669823</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauer &#xa0;R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol. 2009:19:507&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127376</ArticleId><ArticleId IdType="pubmed">19699080</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyed Hosseini &#xa0;E, Riahi Kashani &#xa0;N, Nikzad &#xa0;H, Azadbakht &#xa0;J, Hassani Bafrani &#xa0;H, Haddad &#xa0;KH. The novel coronavirus Disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies. Virology. 2020:551:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7513802</ArticleId><ArticleId IdType="pubmed">33010669</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah &#xa0;J, Liu &#xa0;S, Potula &#xa0;HH, Bhargava &#xa0;P, Cruz &#xa0;I, Force &#xa0;D, Bazerbashi &#xa0;A, Ramasamy &#xa0;R. IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays. BMC Infect Dis. 2021:21:325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025059</ArticleId><ArticleId IdType="pubmed">33827460</ArticleId></ArticleIdList></Reference><Reference><Citation>Shajahan &#xa0;A, Heiss &#xa0;C, Ishihara &#xa0;M, Azadi &#xa0;P. Glycomic and glycoproteomic analysis of glycoproteins-a tutorial. Anal Bioanal Chem. 2017:409:4483&#x2013;4505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5498624</ArticleId><ArticleId IdType="pubmed">28585084</ArticleId></ArticleIdList></Reference><Reference><Citation>Shajahan &#xa0;A, Archer-Hartmann &#xa0;S, Supekar &#xa0;NT, Gleinich &#xa0;AS, Heiss &#xa0;C, Azadi &#xa0;P. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. Glycobiology. 2021:31:410&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665489</ArticleId><ArticleId IdType="pubmed">33135055</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang &#xa0;J, Wan &#xa0;Y, Luo &#xa0;C, Ye &#xa0;G, Geng &#xa0;Q, Auerbach &#xa0;A, Li &#xa0;F. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020:117:11727&#x2013;11734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheskin &#xa0;DJ. Handbook of parametric and nonparametric statistical procedures. 5th ed. Boca Raton: Chapman and Hall / CRC Press; 2020.</Citation></Reference><Reference><Citation>Sperandei &#xa0;S. Understanding logistic regression analysis. Biochem Med (Zagreb). 2014:24:12&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3936971</ArticleId><ArticleId IdType="pubmed">24627710</ArticleId></ArticleIdList></Reference><Reference><Citation>Stencel-Baerenwald &#xa0;JE, Reiss &#xa0;K, Reiter &#xa0;DM, Stehle &#xa0;T, Dermody &#xa0;TS. The sweet spot: defining virus-sialic acid interactions. Nat Rev Microbiol. 2014:12:739&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4791167</ArticleId><ArticleId IdType="pubmed">25263223</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoltzfus &#xa0;JC. Logistic regression: a brief primer. Acad Emerg Med. 2011:18:1099&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pubmed">21996075</ArticleId></ArticleIdList></Reference><Reference><Citation>Suttapitugsakul &#xa0;S, Sun &#xa0;F, Wu &#xa0;R. Recent advances in glycoproteomic analysis by mass spectrometry. Anal Chem. 2020:92:267&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026884</ArticleId><ArticleId IdType="pubmed">31626732</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorici &#xa0;MA, Walls &#xa0;AC, Lang &#xa0;Y, Wang &#xa0;C, Li &#xa0;Z, Koerhuis &#xa0;D, Boons &#xa0;GJ, Bosch &#xa0;BJ, Rey &#xa0;FA, de &#xa0;Groot &#xa0;RJ, et al. &#xa0;Structural basis for human coronavirus attachment to sialic acid receptors. Nat Struct Mol Biol. 2019:26:481&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554059</ArticleId><ArticleId IdType="pubmed">31160783</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull &#xa0;JE, Field &#xa0;RA. Emerging glycomics technologies. Nat Chem Biol. 2007:3:74&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">17235338</ArticleId></ArticleIdList></Reference><Reference><Citation>Udugama &#xa0;B, Kadhiresan &#xa0;P, Kozlowski &#xa0;HN, Malekjahani &#xa0;A, Osborne &#xa0;M, Li &#xa0;VYC, Chen &#xa0;H, Mubareka &#xa0;S, Gubbay &#xa0;JB, Chan &#xa0;WCW. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020:14:3822&#x2013;3835.</Citation><ArticleIdList><ArticleId IdType="pubmed">32223179</ArticleId></ArticleIdList></Reference><Reference><Citation>Uh &#xa0;HW, Klaric &#xa0;L, Ugrina &#xa0;I, Lauc &#xa0;G, Smilde &#xa0;AK, Houwing-Duistermaat &#xa0;JJ. Choosing proper normalization is essential for discovery of sparse glycan biomarkers. Mol Omics. 2020:16:231&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32211690</ArticleId></ArticleIdList></Reference><Reference><Citation>Varki &#xa0;A. Essentials of glycobiology. 3rd ed. &#xa0;Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">27010055</ArticleId></ArticleIdList></Reference><Reference><Citation>Varki &#xa0;A, Cummings &#xa0;RD, Aebi &#xa0;M, Packer &#xa0;NH, Seeberger &#xa0;PH, Esko &#xa0;JD, Stanley &#xa0;P, Hart &#xa0;G, Darvill &#xa0;A, Kinoshita &#xa0;T, et al. &#xa0;Symbol nomenclature for graphical representations of glycans. Glycobiology. 2015:25:1323&#x2013;1324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643639</ArticleId><ArticleId IdType="pubmed">26543186</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigerust &#xa0;DJ, Shepherd &#xa0;VL. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007:15:211&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127133</ArticleId><ArticleId IdType="pubmed">17398101</ArticleId></ArticleIdList></Reference><Reference><Citation>V'Kovski &#xa0;P, Kratzel &#xa0;A, Steiner &#xa0;S, Stalder &#xa0;H, Thiel &#xa0;V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021:19:155&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasak &#xa0;R, Luytjes &#xa0;W, Spaan &#xa0;W, Palese &#xa0;P. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci U S A. 1988:85:4526&#x2013;4529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC280463</ArticleId><ArticleId IdType="pubmed">3380803</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe &#xa0;Y, Bowden &#xa0;TA, Wilson &#xa0;IA, Crispin &#xa0;M. Exploitation of glycosylation in enveloped virus pathobiology. Biochim Biophys Acta Gen Subj. 2019:1863:1480&#x2013;1497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6686077</ArticleId><ArticleId IdType="pubmed">31121217</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe &#xa0;Y, Allen &#xa0;JD, Wrapp &#xa0;D, McLellan &#xa0;JS, Crispin &#xa0;M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020:369:330&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199903</ArticleId><ArticleId IdType="pubmed">32366695</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiederschain &#xa0;G. Glycobiology and human diseases. 1st ed. Boca Raton: CRC Press; 2016.</Citation></Reference><Reference><Citation>Wise &#xa0;J. Long covid: Doctors call for research and surveillance to capture disease. BMJ. 2020:370:m3586.</Citation><ArticleIdList><ArticleId IdType="pubmed">32933925</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfel &#xa0;R, Corman &#xa0;VM, Guggemos &#xa0;W, Seilmaier &#xa0;M, Zange &#xa0;S, Muller &#xa0;MA, Niemeyer &#xa0;D, Jones &#xa0;TC, Vollmar &#xa0;P, Rothe &#xa0;C, et al. &#xa0;Virological assessment of hospitalized patients with COVID-2019. Nature. 2020:581:465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie &#xa0;Y, Butler &#xa0;M. Construction of an InstantPC-derivatized glycan glucose unit database: a foundation work for high-throughput and high-sensitivity glycomic analysis. Glycobiology. 2022:32:289&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">34972858</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie &#xa0;Y, Mota &#xa0;LM, Bergin &#xa0;A, O'Flaherty &#xa0;R, Jones &#xa0;A, Morgan &#xa0;B, Butler &#xa0;M. High-throughput and high-sensitivity N-glycan profiling: a platform for biopharmaceutical development and disease biomarker discovery. Anal Biochem. 2021:623:114205.</Citation><ArticleIdList><ArticleId IdType="pubmed">33891963</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan &#xa0;R, Zhang &#xa0;Y, Li &#xa0;Y, Xia &#xa0;L, Guo &#xa0;Y, Zhou &#xa0;Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020:367:1444&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang &#xa0;X, Yu &#xa0;Y, Xu &#xa0;J, Shu &#xa0;H, Xia &#xa0;J, Liu &#xa0;H, Wu &#xa0;Y, Zhang &#xa0;L, Yu &#xa0;Z, Fang &#xa0;M, et al. &#xa0;Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020:8:475&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zervou &#xa0;FN, Louie &#xa0;P, Stachel &#xa0;A, Zacharioudakis &#xa0;IM, Ortiz-Mendez &#xa0;Y, Thomas &#xa0;K, Aguero-Rosenfeld &#xa0;ME. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol. 2021:93:5409&#x2013;5415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242647</ArticleId><ArticleId IdType="pubmed">33932299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;J, Yuan &#xa0;Q, Wang &#xa0;H, Liu &#xa0;W, Liao &#xa0;X, Su &#xa0;Y, Wang &#xa0;X, Yuan &#xa0;J, Li &#xa0;T, Li &#xa0;J, et al. &#xa0;Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020:71:2027&#x2013;2034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184337</ArticleId><ArticleId IdType="pubmed">32221519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;X, Chen &#xa0;H, Wang &#xa0;H. Glycans of SARS-CoV-2 spike protein in virus infection and antibody production. Front Mol Biosci. 2021:8:629873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076860</ArticleId><ArticleId IdType="pubmed">33928117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu &#xa0;N, Zhang &#xa0;D, Wang &#xa0;W, Li &#xa0;X, Yang &#xa0;B, Song &#xa0;J, Zhao &#xa0;X, Huang &#xa0;B, Shi &#xa0;W, Lu &#xa0;R, et al. &#xa0;A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020:382:727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou &#xa0;KH, O'Malley &#xa0;AJ, Mauri &#xa0;L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007:115:654&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">17283280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwillinger &#xa0;D, Kokoska &#xa0;S. CRC standard probability and statistics tables and formulae. Boca Raton: Chapman &amp; Hall/CRC; 2000</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>